Loading market dashboard
Crescent Biopharma, Inc.
CBIOHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Crescent Biopharma, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $76.89M | $73.58M - $96.22M | -$46.13M | -$3.42 | 3 |
| Dec 2029 | $16.73M | $16.01M - $20.94M | -$10.04M | -$3.74 | 5 |
| Dec 2028 | $8.20M | $7.85M - $10.26M | -$4.92M | -$3.463 | 6 |
| Dec 2027 | $5.58M | $5.34M - $6.99M | -$3.35M | -$3.247 | 4 |
| Dec 2026 | $1.82M | $1.79M - $1.86M | -$1.09M | -$3.199 | 6 |
| Dec 2025 | $7.50M | $7.18M - $9.39M | -$4.50M | -$10.26 | 5 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$51.00 | 0 |
| Dec 2022 | $66.7K | $66.7K - $66.7K | -$40.0K | -$87.00 | 1 |
| Dec 2021 | $835.5K | $835.5K - $835.5K | -$501.3K | -$124.75 | 1 |
| Dec 2020 | $10.00M | $10.00M - $10.00M | -$6.00M | -$108.20 | 1 |
| Dec 2013 | $5.10M | $4.08M - $6.12M | -$48.59M | -$165.73 | 15 |
| Dec 2012 | $114.45M | $91.56M - $137.34M | $2.33M | -$87.20 | 7 |